copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Chroma Medicine - 2025 Company Profile - Tracxn Chroma Medicine is a series B company based in Cambridge (United States), founded in 2020 It operates as a Developer of an epigenetic editing platform for genomic medicines Chroma Medicine has raised $260M in funding from investors like Atlas Venture, Google Ventures and Cormorant-asset The company has 17 active competitors, including 6 funded and 3 that have exited Its top competitor s
Chroma Medicine Revenue, Growth Competitor Profile Chroma Medicine is classified as operating in the Medicinal Botanical Manufacturing industry, NAICS Code 325411 Chroma Medicine Annual Revenue and Growth Rate
Chroma Medicine, Inc. (CIK: 0001967386) EDGAR, Information, Filings . . . About Chroma Medicine, Inc Chroma Medicine, Inc (CIK: 0001967386) is an American company incorporated in the state of Massachusetts Head office is located at 201 BROOKLINE AVE, SUITE 1101, BOSTON, Massachusetts, 02215 Work in the industry N A Chroma Medicine, Inc is a public company and trade via Over-The-Counter (OTC)
Chroma Medicine - 2025 Funding Rounds List of Investors - Tracxn Chroma Medicine has raised a total funding of $260M over 3 rounds from 18 investors Investors include Sofinnova Investments, Omega Funds and 16 others Their latest funding round was of $135M on Feb 08, 2023
Epigenetics Market Size to Hit USD 7. 72 Billion by 2034 Chroma Medicine, Inc (Chroma) was founded in November 2021 with a capital of USD 125 million to address a wide range of diseases and emerge as the technique of choice for the regulation of gene expression Due to the aforementioned factors, the market in this region should grow
Who Owns Chroma Medicine Company? - canvasbusinessmodel. com Who Really Controls Chroma Medicine? Unraveling the ownership of a biotech company like Chroma Medicine is key to understanding its potential in the rapidly evolving field of epigenetic editing This Chroma Medicine Canvas Business Model helps to understand the company's strategic direction A pivotal shift occurred in December 2024 when Chroma Medicine merged with Nvelop Therapeutics to form